Significados de cv disease en inglés

Subclinical CV disease was associated with age and dyslipidemia but not with other risk factors.

These effects seem particularly important for reducing risk of CV disease in patients with the metabolic syndrome.

This study provides preliminary data for developing an integrated model of multidisciplinary care for the management of CV disease.

Increasing the understanding of the pathogenesis of various CV diseases may provide novel therapeutic targets to improve their prevention and treatment.

The metabolic syndrome (MS) represents a cluster of cardiovascular (CV ) risk factors associated to CV disease and type 2 diabetes.

Additionally, recent studies suggest that GnRH antagonists may significantly reduce CV risk compared to GnRH agonists, particularly in men with pre-existing CV disease.

Because AstraZeneca's study also looked at patients without established CV disease, it potentially opens up a larger market that also covers so-called primary prevention.

Coronary and CV disease biomarkers in UWS correlated better with serum than with LS and GS based on group status and measures of time effect.